Cited by 220Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatmentsNeurological Disease Mechanisms and Treatments

Relation of neuropathology to cognition in persons without cognitive impairment

Open access
Bennett, David A., Wilson, Robert S., Boyle, Patricia A., Buchman, Aron S., Schneider, Julie A.·2012·Annals of Neurology

Abstract

Objective: A study was undertaken to examine the relation of Alzheimer disease (AD) pathology, cerebral infarcts, and Lewy body (LB) pathology to cognition in persons without cognitive impairment. Methods: Persons without dementia from 2 cohort studies of aging, the Religious Orders Study and the Memory and Aging Project, agreed to annual clinical evaluation and brain donation. The studies had 19 neuropsychological performance tests in common that assessed 5 cognitive domains. For 296 persons without cognitive impairment who died and underwent postmortem assessment, we quantified AD pathology as a global pathology score, and as amyloid load, paired helical filament tau‐positive (PHFtau) tangle density, cerebral infarcts, and LB pathology. Linear regression was used to examine the relation of neuropathology to cognitive abilities, controlling for demographics. Results: Nearly all persons had AD pathology with >¾ exhibiting amyloid; 22% had macroscopic and 24% had microscopic infarctions, and 13% had LB pathology. The global measure of AD pathology was related to global cognition (p = 0.008), whereas infarcts and Lewy bodies were not. Amyloid load was related to global cognition (p < 0.05), with only a trend for tangles (p = 0.08). In analyses of cognitive domains, AD pathology (p = 0.006), PHFtau tangles (p = 0.03), and macroscopic infarctions (p = 0.02) were related to episodic memory, with a trend for amyloid load (p = 0.06); AD pathology (p = 0.02) and amyloid load (p = 0.03) were related to working memory. Findings for global cognition and episodic memory were stronger in additional analyses with neocortical amyloid and mesial temporal tangles. Interpretation: AD pathology and macroscopic infarctions are common in older persons without cognitive impairment and are related to episodic and working memory. ANN NEUROL 2012;72:599–609

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ana.23654

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 31

  1. [1]Jack CR Jr Knopman DS Jagust WJ Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol 2010 9 119 28 20083042 PMC2819840
  2. [2]Sperling RA Aisen PS Beckett LA Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011 7 280 92 21514248 PMC3220946
  3. [3]Galvin JE Powlishta KK Wilkins K Predictors of preclinical Alzheimer disease and dementia: a clinicopathologic study. Arch Neurol 2005 62 758 765 15883263
  4. [4]Petersen RC Parisi JE Dickson DW Neuropathologic features of amnestic mild cognitive impairment. Arch Neurol 2006 63 665 72 16682536
  5. [5]Sonnen JA Larson EB Crane PK Pathological correlates of dementia in a longitudinal, population-based sample of aging. Ann Neurol 2007 62 406 13 17879383
  6. [6]Mormino EC Kluth JT Madison CM Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects. Brain 5 2009 132 1310 23 19042931 PMC2677792
  7. [8]Bennett DA Schneider JA Aggarwal NT Decision rules guiding the clinical diagnosis of Alzheimer's disease in two community-based cohort studies compared to standard practice in a clinic-based cohort study. Neuroepidemiology 2006 27 169 76 17035694
  8. [9]Bennett DA Wilson RS Schneider JA Natural history of mild cognitive impairment in older persons. Neurology 2002 59 198 205 12136057
  9. [10]Boyle PA Wilson RS Aggarwal NT Tang Y Bennett DA Mild cognitive impairment: risk of Alzheimer disease and rate of cognitive decline. Neurology 2006 67 441 5 16894105
  10. [11]Bennett DA Wilson RS Schneider JA Apolipoprotein E4 allele, Alzheimer's disease pathology, and the clinical expression of Alzheimer's disease. Neurology 2003 60 246 252 12552039
  11. [12]Bennett DA Schneider JA Arnold SE Tang Y Wilson RS The effect of social networks on the relation between Alzheimer's disease pathology and level of cognitive function in old people: a longitudinal cohort study. The Lancet Neurology 2006 5 406 412 16632311
  12. [13]Bennett DA Schneider JA Wilson RS Bienias JL Arnold SE Neurofibrillary tangles mediate the association of amyloid load and with clinical Alzheimer's disease and level of cognitive function. Archives of Neurology 2004 61 378 384 15023815
  13. [14]Schneider JA Arvanitakis Z Leurgans SE Bennett DA The neuropathology of probable Alzheimer disease and mild cognitive impairment. Ann Neurol 2009 66 200 8 19743450 PMC2812870
  14. [15]Arvanitakis Z Leurgans SE Barnes LL Bennett DA Schneider JA Microinfarct pathology, dementia, and cognitive systems. Stroke 2011 42 722 7 21212395 PMC3042494
  15. [18]Riley KP Snowdon DA Markesbery WR Alzheimer's neurofibrillary pathology and the spectrum of cognitive function: findings from the Nun Study. Ann Neurol 2002 51 567 577 12112102
  16. [19]Markesbery WR Schmitt FA Kryscio RJ Davis DG Smith CD Wekstein DR Neuropathologic substrate of mild cognitive impairment. Arch Neurol 2006 63 38 46 16401735
  17. [22]SantaCruz KS Sonnen JA Pezhouh MK Desrosiers MF Nelson PT Tyas SL Alzheimer disease pathology in subjects without dementia in 2 studies of aging: the Nun Study and the Adult Changes in Thought Study. J Neuropathol Exp Neurol 2011 70 832 40 21937909 PMC3445265
  18. [23]Guillozet AL Weintraub S Mash DC Mesulam MM Neurofibrillary tangles, amyloid, and memory in aging and mild cognitive impairment. Arch Neurol 2003 60 729 736 12756137
  19. [26]Knopman DS Parisi JE Salviati A Neuropathology of cognitively normal elderly. J Neuropathol Exp Neurol 2003 62 1087 95 14656067
  20. [30]Carey CL Kramer JH Josephson SA Subcortical lacunes are associated with executive dysfunction in cognitively normal elderly. Stroke 2008 39 397 402 18096844 PMC2443738
  21. [31]Lim C Alexander MP Stroke and episodic memory disorders. Neuropsychologia 2009 47 3045 58 19666037
  22. [32]Kantarci K Lowe V Przybelski SA APOE modifies the association between Aβ load and cognition in cognitively normal older adults. Neurology In press PMC3280056 22189452
  23. [34]Hardy J The amyloid hypothesis for Alzheimer's disease: a critical reappraisal. J Neurochem 2009 110 1129 34 19457065
  24. [35]Dickson DW Kouri N Murray ME Josephs KA Neuropathology of frontotemporal lobar degeneration-tau (FTLD-tau). J Mol Neurosci 2011 45 384 9 21720721 PMC3208128
  25. [36]Thal DR Rüb U Orantes M Braak H Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology 2002 58 1791 800 12084879
  26. [37]Klunk WE Engler H Nordberg A Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann Neurol 2004 55 306 19 14991808
  27. [38]Braak H Braak E Neuropathological stageing of Alzheimerrelated changes. Acta Neuropathol (Berl) 1991 82 239 259 1759558
  28. [40]Ghoshal N García-Sierra F Wuu J Tau conformational changes correspond to impairments of episodic memory in mild cognitive impairment and Alzheimer's disease. Exp Neurol 2002 177 475 93 12429193
  29. [41]Raji CA Lopez OL Kuller LH Carmichael OT White matter lesions and brain gray matter volume in cognitively normal elders. Neurobiol Aging 2011 [Epub] PMC3248984 21943959 Ghoshal N García-Sierra F Wuu J Tau conformational changes correspond to impairments of episodic memory in mild cognitive impairment and Alzheimer's disease. Exp Neurol 2002 177 475 93 12429193
  30. [42]Buchman AS Shulman JM Nag S Leurgans SE Arnold SE Morris MC Schneider JA Bennett DA Nigral pathology and parkinsonian signs in elders without Parkinson's disease. Annals of Neurology 2012 71 258 66 22367997 PMC3367476
  31. [43]Wilson RS Yu L Schneider JA Arnold SE Buchman AS Bennett DA Lewy bodies and olfactory dysfunction in old age. Chem Senses. 2011 36 367 73 PMC3073534 21257733

Cited by

Sorted by citations

Authors
Bennett, D. A., Wilson, R. S., Boyle, P. A., Buchman, A. S., & Schneider, J. A.
Affiliations
Rush University Medical Center (US)
Corresponding author
Bennett, David A.
Venue
Annals of Neurology
Publisher
Wiley
Published
2012-10
Volume
72
Issue
4
Pages
599-609
ISSN
  • 0364-5134 (ISSN-L)
  • 1531-8249
OpenAlex
W2034030646
Cited by
220
References
13
Citations by year
2026: 4 · 2025: 6 · 2024: 10 · 2023: 16 · 2022: 12 · 2021: 22 · 2020: 24 · 2019: 20 · 2018: 20 · 2017: 14 · 2016: 16 · 2015: 14 · 2014: 16 · 2013: 24 · 2012: 2
FWCI
12.79
Type
journal article
Language
en
Open access
Locations
  • Annals of Neurology (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Institute on Aging (R01AG017917, P30-AG 10161, R01-AG34374, R01‐AG17917, R01 AG15819, R01AG015819, P30AG010161, R01AG034374)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
Keywords
Alzheimer disease pathology, cerebral infarction, Lewy body pathology, amyloid load, episodic memory, working memory, neuropathology, Religious Orders Study, brain donation
MeSH terms
Aged, 80 and over, Aging, Alzheimer Disease, Autopsy, Brain, Cognition, Cognition Disorders, Educational Status, Female, Humans, Male, Memory, Memory, Short-Term, Nervous System Diseases, Neuropsychological Tests, Psychomotor Performance, Temporal Lobe, Cohort Studies, Linear Models, Amyloid beta-Peptides, tau Proteins, Neocortex, Brain Infarction, Lewy Body Disease, Memory, Episodic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review